Ignite Creation Date:
2025-12-24 @ 3:58 PM
Ignite Modification Date:
2026-03-18 @ 2:18 AM
Study NCT ID:
NCT01705392
Status:
TERMINATED
Last Update Posted:
2017-02-24
First Post:
2012-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab vs Dacarbazine in Metastatic Melanoma
Sponsor:
Haukeland University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2012/910
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None